4//SEC Filing
Tan Aik Na 4
Accession 0000950170-25-110287
CIK 0001631574other
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 8:00 PM ET
Size
8.4 KB
Accession
0000950170-25-110287
Insider Transaction Report
Form 4
Tan Aik Na
Director
Transactions
- Sale
Ordinary Shares
2025-08-15$9.25/sh−21,000$194,250→ 40,388 total - Exercise/Conversion
Ordinary Shares
2025-08-15$9.13/sh+21,000$191,730→ 61,388 total - Exercise/Conversion
Share Option (right to buy)
2025-08-15−21,000→ 0 totalExercise: $9.13Exp: 2025-08-18→ Ordinary Shares (21,000 underlying)
Footnotes (2)
- [F1]The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.
- [F2]These share options are fully vested.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001821285
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 8:00 PM ET
- Size
- 8.4 KB